logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Chemical Intermediates > (7-metho-xy-4-oxo-1H-quinazolin-6-yl) Acetate CAS 179688-53-0

(7-metho-xy-4-oxo-1H-quinazolin-6-yl) Acetate CAS 179688-53-0

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 179688-53-0

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
179688-53-0
Appearance::
Brown Solid Powder
Molecular Formula::
C11H10N2O4
Molecular Weight::
234.20800
EINECS NO::
808-050-2
MDL NO::
MFCD09833010
CAS NO::
179688-53-0
Appearance::
Brown Solid Powder
Molecular Formula::
C11H10N2O4
Molecular Weight::
234.20800
EINECS NO::
808-050-2
MDL NO::
MFCD09833010
(7-metho-xy-4-oxo-1H-quinazolin-6-yl) Acetate CAS 179688-53-0

Product Description:

Product Name: (7-metho-xy-4-oxo-1H-quinazolin-6-yl) acetate CAS NO: 179688-53-0

 

 

Synonyms:

6-Acetoxy-7-metho-xy-3,4-dihydroquinazolin-4-one;

6-Acetoxy-7-metho-xy-4-quinazolinol;

3,4-dihydro-4-oxo-6-acetyloxy-7-metho-xy-quinazoline;

 

 

Chemical & Physical Properties:

Appearance: Brown solid powder

Assay :≥99.0%

Density: 1.39

Boiling Point: 452.391℃ at 760 mmHg

Melting Point: 293℃

Flash Point: 227.398℃

Refractive Index: 1.612

Vapor Pressure: 0mmHg at 25℃

 

 

Safety Information:

HS Code: 2933990090

 

 

3, 4-dihydro-7-metho-xy-4-oxy quinazoline-6-alcohol acetate is a key intermediate for the synthesis of EGFR inhibitor Gefitinib and pan-HER inhibitor Poziotinib and other anti-tumor small molecules. 3, 4-dihydro-7-metho-xy-4-oxy quinazoline-6-alcohol acetate can be used as a pharmaceutical synthesis intermediate, can be prepared from 6-hydroxy-7-metho-xy-4-ketoquinazoline-as the reaction material, can be used to prepare the intermediate 7-metho-xy-6-acetoxy-4-chloroquinazoline-7-metho-xy. 3, 4-dihydro-7-metho-xy-4-oxy quinazoline-6-alcohol acetate is a white to light brown solid with strong inhibitory activity against VEGFR-2/HDAC and human breast cancer cell line MCF-7. Mainly used in pharmaceutical synthesis intermediates and cosmetics.

 

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.